Literature DB >> 28634616

Lineage switch from B acute lymphoblastic leukemia to acute monocytic leukemia with persistent t(4;11)(q21;q23) and cytogenetic evolution under CD19-targeted therapy.

Estelle Balducci1, Vanessa Nivaggioni2, John Boudjarane1, Lakhdar Bouriche2, Ilhem Rahal3, Denis Bernot2, Emilie Alazard1, Nicolas Duployez4, Nathalie Grardel4, Isabelle Arnoux2, Marina Lafage-Pochitaloff1, Gérard Michel3, Bertrand Nadel5, Marie Loosveld6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28634616     DOI： 10.1007/s00277-017-3050-6

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  7 in total

1.  Spontaneous reversion of a lineage switch following an initial blinatumomab-induced ALL-to-AML switch in MLL-rearranged infant ALL.

Authors:  Matthias Wölfl; Mareike Rasche; Matthias Eyrich; Renate Schmid; Dirk Reinhardt; Paul G Schlegel
Journal:  Blood Adv       Date:  2018-06-26

2.  Transient atypical monocytosis after α/β T-cell-depleted haploidentical hematopoietic stem cell transplantation.

Authors:  Angela Liou; John Van Arnam; Vinodh Pillai; Alix E Seif; Sarah K Tasian; Charles A Phillips
Journal:  Pediatr Blood Cancer       Date:  2019-12-22       Impact factor: 3.167

3.  Lineage Conversion in Pediatric B-Cell Precursor Acute Leukemia under Blinatumomab Therapy.

Authors:  Alexandra Semchenkova; Ekaterina Mikhailova; Alexander Komkov; Marina Gaskova; Ruslan Abasov; Evgenii Matveev; Marat Kazanov; Ilgar Mamedov; Anna Shmitko; Vera Belova; Anna Miroshnichenkova; Olga Illarionova; Yulia Olshanskaya; Grigory Tsaur; Tatiana Verzhbitskaya; Natalia Ponomareva; Gleb Bronin; Konstantin Kondratchik; Larisa Fechina; Yulia Diakonova; Liudmila Vavilova; Natalia Myakova; Galina Novichkova; Alexey Maschan; Michael Maschan; Elena Zerkalenkova; Alexander Popov
Journal:  Int J Mol Sci       Date:  2022-04-05       Impact factor: 5.923

Review 4.  Transcriptional and Microenvironmental Regulation of Lineage Ambiguity in Leukemia.

Authors:  Tianyuan Hu; Rebecca Murdaugh; Daisuke Nakada
Journal:  Front Oncol       Date:  2017-11-06       Impact factor: 6.244

5.  Immunotherapy- (Blinatumomab-) Related Lineage Switch of KMT2A/AFF1 Rearranged B-Lymphoblastic Leukemia into Acute Myeloid Leukemia/Myeloid Sarcoma and Subsequently into B/Myeloid Mixed Phenotype Acute Leukemia.

Authors:  Rui R He; Zacharia Nayer; Matthew Hogan; Raymund S Cuevo; Kimberly Woodward; David Heyer; Christine A Curtis; Jess F Peterson
Journal:  Case Rep Hematol       Date:  2019-12-07

6.  LAMP-5 is an essential inflammatory-signaling regulator and novel immunotherapy target for mixed lineage leukemia-rearranged acute leukemia.

Authors:  Gabriel Gracia-Maldonado; Jason Clark; Matthew Burwinkel; Brenay Greenslade; Mark Wunderlich; Nathan Salomonis; Dario Leone; Evelina Gatti; Philippe Pierre; Ashish R Kumar; Lynn H Lee
Journal:  Haematologica       Date:  2022-04-01       Impact factor: 9.941

Review 7.  Does lineage plasticity enable escape from CAR-T cell therapy? Lessons from MLL-r leukemia.

Authors:  Wenjuan Liao; M Eric Kohler; Terry Fry; Patricia Ernst
Journal:  Exp Hematol       Date:  2021-07-21       Impact factor: 3.084
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.